Nan Fung Group Holdings »

Cabaletta Bio shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $718k 47k 15.22
2023-06-30 $531k 41k 12.91

More positions owned by Nan Fung Group Holdings

Karuna Therapeutics Ord
Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Seagen
Oculis Holding Ordinary Shares (OCS)
Somalogic Class A Com
Exscientia Ads (EXAI)
Xenon Pharmaceuticals (XENE)
Merus N V (MRUS)
Replimune Group (REPL)
Kalvista Pharmaceuticals (KALV)
Beigene Sponsored Adr (BGNE)
Alpine Immune Sciences (ALPN)
Incyte Corporation (INCY)
Geron Corporation (GERN)

View all positions for Nan Fung Group Holdings

Top funds holding Cabaletta Bio

Jennison Associates
Fred Alger Management
VR Adviser
Vanguard Group
Lynx1 Capital Management
Deerfield Management Company
Perceptive Advisors
Holocene Advisors
Commodore Capital
Redmile Group
Wellington Management Company
T. Rowe Price Associates
Ikarian Capital
Victory Capital Management
Blackstone Group

View all funds holding Cabaletta Bio